Patrick Balthrop, Tom Erickson

Premium

Patrick Balthrop joins Luminex of Austin, Texas, as chief executive officer and president, the company announced Monday. He replaced interim chief executive officer Tom Erickson, who held the post for nearly two years and will stand for election to the company’s board of directors at the annual shareholders’ meeting this week. Balthrop joins Luminex, which manufactures and sells the xMap bead assay system for life sciences research, from his position as president of Fisher Healthcare, a Fisher Scientific International company.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.